Issues with COVID-19 vaccine manufacturing in Europe has left Canada receiving fewer doses in recent weeks than the federal government initially predicted, but the drop in supply offers an opportunity for governments to get the planning right for when mass vaccinations begin later in the year when supply ramps up again, experts say.